Dana Madison, M.D.,Ph.D.
- click here
- 503 494-2544
Dr Madison graduated with a MD and PhD (Biochemistry and Molecular Biology) from the University of Connecticut in 1998. He completed a residency in Internal Medicine at OHSU in 2000 and an Endocrinology fellowship at OHSU in 2003. Dr Madison is board certified in Internal Medicine and Endocrinology. Dr Madison serves as Co-Director of the Thyroid and Parathyroid Program, consulting with patients and providing a full range of diagnosis and treatment services to patients with thyroid and parathyroid disorders. His research interests are in molecular mechanisms of tumor metastasis and transcription.
"Nicotinamide adenine dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a switching tryptophan,"
"The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest,"
"C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21waf1/cip1 promoter,"
"A Vast Differential,"
"Severe dystrophic calcification confounded by secondary hyperparathyroidism in a patient with thyroid lymphoma and CREST syndrome,"